What is the Return on Assets (ROA) of BioCardia this year?
The Return on Assets (ROA) of BioCardia is -3.87 undefined this year.
BioCardia ROA 2024
BioCardia ROA
-3.87
BioCardia Dividend yield
Ticker
BCDA
ISIN
US09060U5074
WKN
A2PLXH
In 2024, BioCardia's return on assets (ROA) was -3.87, a 218.42% increase from the -1.22 ROA in the previous year.
BioCardia Aktienanalyse
What does BioCardia do?
BioCardia Inc is a medical technology company based in San Carlos, California, founded in 1994. They specialize in the development of medical devices used in the treatment of heart diseases. BioCardia has three main product lines: the Helix™ Biotherapy Platform, the Morph™ Transseptal Systems, and the CYPHER Select™ Balloon Catheter. The Helix™ Biotherapy Platform was developed to treat cardiovascular diseases using regenerative medicine. The system utilizes patient's own stem cells to repair damaged heart tissue and reduce the risk of heart attacks. This therapy method can significantly improve the quality of life and survival chances of patients with heart diseases. The Morph™ Transseptal Systems are used for minimally invasive removal of blood clots. They consist of a flexible guide wire and a catheter device that allows the doctor to remove the clot in the heart without performing an open surgery. This procedure is faster, safer, and less invasive than conventional methods. The CYPHER Select™ Balloon Catheter is used to open narrowed arteries in the heart. The balloon is inserted into the artery and inflated to break up the narrowing. Then, a medication is released to prevent the recurrence of the narrowing. This procedure is minimally invasive and enables faster recovery of patients. BioCardia is also involved in clinical research and collaborates closely with renowned institutions such as the Stanford University Medical Center. Through clinical studies, BioCardia collects important data on the efficacy and safety of its products. The results of these studies are published in medical journals and contribute to the advancement of medical practice. BioCardia's business model is based on the development and commercialization of innovative medical devices for the treatment of heart diseases. The company has built a portfolio of products and platforms that allow it to specialize in various areas of cardiovascular medicine. BioCardia also utilizes partnerships and collaborations to market its products and services. Overall, BioCardia is one of the leading companies in the field of medical devices for the treatment of heart diseases. With a portfolio of innovative products and a strong presence in medical research, BioCardia is well positioned to solidify its position as a market leader in the industry. BioCardia ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding BioCardia's Return on Assets (ROA)
BioCardia's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing BioCardia's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider BioCardia's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in BioCardia’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about BioCardia Stock
What was the ROA of BioCardia compared to the previous year?
The ROA of BioCardia has increased by 218.42% compared to the previous year.
What consequences do high ROA have for investors of BioCardia?
A high ROA is advantageous for investors of BioCardia, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in BioCardia?
A low ROA can be unfavorable for investors of BioCardia as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of BioCardia affect the company?
An increase in ROA of BioCardia can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of BioCardia impact the company?
A reduction in the ROA of BioCardia can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of BioCardia?
Some factors that can influence the ROA of BioCardia include revenue, operating costs, asset structure, and industry average.
Why is the ROA of BioCardia important for investors?
The ROA of BioCardia is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can BioCardia take to improve ROA?
To improve ROA, BioCardia can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does BioCardia pay?
Over the past 12 months, BioCardia paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, BioCardia is expected to pay a dividend of 0 USD.
What is the dividend yield of BioCardia?
The current dividend yield of BioCardia is .
When does BioCardia pay dividends?
BioCardia pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of BioCardia?
BioCardia paid dividends every year for the past 0 years.
What is the dividend of BioCardia?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is BioCardia located?
BioCardia is assigned to the 'Health' sector.
Wann musste ich die Aktien von BioCardia kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of BioCardia from 5/8/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/8/2024.
When did BioCardia pay the last dividend?
The last dividend was paid out on 5/8/2024.
What was the dividend of BioCardia in the year 2023?
In the year 2023, BioCardia distributed 0 USD as dividends.
In which currency does BioCardia pay out the dividend?
The dividends of BioCardia are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von BioCardia
Our stock analysis for BioCardia Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BioCardia Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
